TD Asset Management
MED icon

TD Asset Management’s Medifast MED Stock Holding History

TD Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,400
Closed -$399K – 1399
2024
Q1 		$399K Buy
10,400
+800
+8% +$38.7K ﹤0.01% 1319
2023
Q4 		$645K Buy
9,600
+500
+5% +$34.8K ﹤0.01% 1264
2023
Q3 		$681K Buy
9,100
+2,400
+36% +$213K ﹤0.01% 1215
2023
Q2 		$617K Hold
6,700
– – ﹤0.01% 1221
2023
Q1 		$695K Buy
6,700
+2,900
+76% +$321K ﹤0.01% 1209
2022
Q4 		$438K Buy
+3,800
New +$442K ﹤0.01% 1307
2021
Q4 		– Sell
-47,756
Closed -$9.2M – 1522
2021
Q3 		$9.2M Buy
47,756
+9,326
+24% +$2.29M 0.01% 671
2021
Q2 		$11M Buy
+38,430
New +$10.4M 0.01% 629
2020
Q2 		– Sell
-9,000
Closed -$563K – 1390
2020
Q1 		$563K Buy
+9,000
New +$819K ﹤0.01% 1150
2018
Q4 		– Sell
-22,500
Closed -$4.99M – 1423
2018
Q3 		$4.99M Sell
22,500
-100
-0.4% -$20.3K 0.01% 729
2018
Q2 		$3.62M Sell
22,600
-14,600
-39% -$1.87M 0.01% 785
2018
Q1 		$3.48M Buy
37,200
+200
+0.5% +$14.9K 0.01% 756
2017
Q4 		$2.58M Buy
37,000
+6,000
+19% +$398K ﹤0.01% 831
2017
Q3 		$1.84M Buy
31,000
+400
+1% +$19.9K ﹤0.01% 887
2017
Q2 		$1.27M Buy
30,600
+1,200
+4% +$52.2K ﹤0.01% 984
2017
Q1 		$1.3M Buy
29,400
+4,800
+20% +$207K ﹤0.01% 977
2016
Q4 		$1.02M Sell
24,600
-1,300
-5% -$52.4K ﹤0.01% 1020
2016
Q3 		$979K Buy
+25,900
New +$928K ﹤0.01% 1014

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

TD Asset Management's MED Position: Q2 2024 in Review

TD Asset Management sold out of Medifast (MED) in Q2 2024, closing a stake of 10,400 shares — an estimated $399K sold.

TD Asset Management first reported a position in MED in Q3 2016 and held it in 18 quarters. The position peaked at $11M in Q2 2021. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • TD Asset Management reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • TD Asset Management sold 10,400 Medifast shares in Q2 2024, an estimated $399K.
  • TD Asset Management first reported a position in Medifast in Q3 2016 and held it in 18 quarters.
  • TD Asset Management's Medifast position peaked at $11M in Q2 2021.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on TD Asset Management's 13F filing for Q2 2024, filed 2 Aug 2024.